Market Tracker

03/23 8:06am ET

Enzo Biochem Inc (NYSE:ENZ)

7.88
Delayed Data
As of Mar 22
 +0.01 / +0.13%
Today’s Change
4.28
Today|||52-Week Range
7.93
+13.54%
Year-to-Date

Today’s Trading

Previous close7.87
Today’s open7.77
Day’s range7.77 - 7.92
Volume185,883
Average volume (3 months)176,945
Market cap$364.8M
Dividend yield--
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+40.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+5.30%
P/E ratio11.6
Price/Sales3.16
Price/Book4.07

Competitors

 Today’s
change
Today’s
% change
NVTAInvitae Corp+0.24+2.43%
NTRANatera Inc-0.05-0.58%
PTIProteostasis Therape...-0.38-3.39%
RDNTRadNet Inc-0.10-1.74%
Data as of 03/22/2017

Financials

Last reporting dateMarch 13, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$102.8M
Annual profit (last year)$45.3M
Net profit margin44.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer &
Class II Director
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts